152 related articles for article (PubMed ID: 32210272)
1. DNA methylation ambiguity in the Fibrillin-1 (FBN1) CpG island shore possibly involved in Marfan syndrome.
Arai Y; Umeyama K; Okazaki N; Nakano K; Nishino K; Nagashima H; Ohgane J
Sci Rep; 2020 Mar; 10(1):5287. PubMed ID: 32210272
[TBL] [Abstract][Full Text] [Related]
2. Establishment of DNA methylation patterns of the Fibrillin1 (FBN1) gene in porcine embryos and tissues.
Arai Y; Umeyama K; Takeuchi K; Okazaki N; Hichiwa N; Yashima S; Nakano K; Nagashima H; Ohgane J
J Reprod Dev; 2017 Apr; 63(2):157-165. PubMed ID: 28111381
[TBL] [Abstract][Full Text] [Related]
3. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome.
Milewicz DM; Grossfield J; Cao SN; Kielty C; Covitz W; Jewett T
J Clin Invest; 1995 May; 95(5):2373-8. PubMed ID: 7738200
[TBL] [Abstract][Full Text] [Related]
4. Qualitative and quantitative analysis of FBN1 mRNA from 16 patients with Marfan Syndrome.
Tjeldhorn L; Amundsen SS; Barøy T; Rand-Hendriksen S; Geiran O; Frengen E; Paus B
BMC Med Genet; 2015 Dec; 16():113. PubMed ID: 26684006
[TBL] [Abstract][Full Text] [Related]
5. Reference Expression Profile of Three
Benarroch L; Aubart M; Gross MS; Arnaud P; Hanna N; Jondeau G; Boileau C
Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30754709
[TBL] [Abstract][Full Text] [Related]
6. Homozygous and compound heterozygous mutations in the FBN1 gene: unexpected findings in molecular diagnosis of Marfan syndrome.
Arnaud P; Hanna N; Aubart M; Leheup B; Dupuis-Girod S; Naudion S; Lacombe D; Milleron O; Odent S; Faivre L; Bal L; Edouard T; Collod-Beroud G; Langeois M; Spentchian M; Gouya L; Jondeau G; Boileau C
J Med Genet; 2017 Feb; 54(2):100-103. PubMed ID: 27582083
[TBL] [Abstract][Full Text] [Related]
7. The clinical presentation of Marfan syndrome is modulated by expression of wild-type FBN1 allele.
Aubart M; Gross MS; Hanna N; Zabot MT; Sznajder M; Detaint D; Gouya L; Jondeau G; Boileau C; Stheneur C
Hum Mol Genet; 2015 May; 24(10):2764-70. PubMed ID: 25652400
[TBL] [Abstract][Full Text] [Related]
8. Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype?
Hutchinson S; Furger A; Halliday D; Judge DP; Jefferson A; Dietz HC; Firth H; Handford PA
Hum Mol Genet; 2003 Sep; 12(18):2269-76. PubMed ID: 12915484
[TBL] [Abstract][Full Text] [Related]
9. Expression of FBN1 during adipogenesis: Relevance to the lipodystrophy phenotype in Marfan syndrome and related conditions.
Davis MR; Arner E; Duffy CR; De Sousa PA; Dahlman I; Arner P; Summers KM
Mol Genet Metab; 2016 Sep; 119(1-2):174-85. PubMed ID: 27386756
[TBL] [Abstract][Full Text] [Related]
10. A nonsense variant in FBN1 caused autosomal dominant Marfan syndrome in a Chinese family: a case report.
Niu Y; Huang S; Wang Z; Xu P; Wang L; Li J; Gao M; Gao X; Gao Y
BMC Med Genet; 2020 Oct; 21(1):211. PubMed ID: 33087052
[TBL] [Abstract][Full Text] [Related]
11. Experimental and bioinformatic characterisation of the promoter region of the Marfan syndrome gene, FBN1.
Summers KM; Bokil NJ; Baisden JM; West MJ; Sweet MJ; Raggatt LJ; Hume DA
Genomics; 2009 Oct; 94(4):233-40. PubMed ID: 19573590
[TBL] [Abstract][Full Text] [Related]
12. Mutation screening in the FBN1 gene responsible for Marfan syndrome and related disorder in Chinese families.
Gong B; Yang L; Wang Q; Ye Z; Guo X; Yang C; Hao F; Shi Y; Huang Y; Qu C; Yang Z
Mol Genet Genomic Med; 2019 Apr; 7(4):e00594. PubMed ID: 30838813
[TBL] [Abstract][Full Text] [Related]
13. FBN1 exon 2 splicing error in a patient with Marfan syndrome.
Guo D; Tan FK; Cantu A; Plon SE; Milewicz DM
Am J Med Genet; 2001 Jun; 101(2):130-4. PubMed ID: 11391655
[TBL] [Abstract][Full Text] [Related]
14. Autosomal dominant Marfan syndrome caused by a previously reported recessive FBN1 variant.
Overwater E; Efrat R; Barge-Schaapveld DQCM; Lakeman P; Weiss MM; Maugeri A; van Tintelen JP; Houweling AC
Mol Genet Genomic Med; 2019 Feb; 7(2):e00518. PubMed ID: 30485715
[TBL] [Abstract][Full Text] [Related]
15. Novel
Yao X; Wu J; Chen J
Ann Clin Lab Sci; 2019 Sep; 49(4):539-545. PubMed ID: 31471346
[TBL] [Abstract][Full Text] [Related]
16. Detection and a functional characterization of the novel FBN1 intronic mutation underlying Marfan syndrome: case presentation.
Wypasek E; Potaczek DP; Hydzik M; Stapor R; Raczkowska-Muraszko M; Weiss J; Maugeri A; Undas A
Clin Chem Lab Med; 2018 Mar; 56(4):87-91. PubMed ID: 29220879
[No Abstract] [Full Text] [Related]
17. Betaglycan (TGFBR3) up-regulation correlates with increased TGF-β signaling in Marfan patient fibroblasts in vitro.
Groeneveld ME; Bogunovic N; Musters RJP; Tangelder GJ; Pals G; Wisselink W; Micha D; Yeung KK
Cardiovasc Pathol; 2018; 32():44-49. PubMed ID: 29198452
[TBL] [Abstract][Full Text] [Related]
18.
Wang JJ; Yu B; Sun Y; Song X; Wang DW; Li Z
Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292727
[TBL] [Abstract][Full Text] [Related]
19. Genetic testing of the FBN1 gene in Chinese patients with Marfan/Marfan-like syndrome.
Yang H; Luo M; Chen Q; Fu Y; Zhang J; Qian X; Sun X; Fan Y; Zhou Z; Chang Q
Clin Chim Acta; 2016 Aug; 459():30-35. PubMed ID: 27234404
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of FBN1 genemutations in a pedigree with Marfan syndrome].
Zheng Q; Li KL; Dai GL; Xiong D; Yao MY; Chen X; Li YM; Zhang YY; Li HR; Cao Y
Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(34):2702-2706. PubMed ID: 36096698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]